Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides (Q44040170)

29 November 2017

title

Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides (English)

1 reference

29 November 2017

Ralf Kronenwett

1

1 reference

29 November 2017

Thorsten Gräf

2

1 reference

29 November 2017

Wolfgang Nedbal

3

1 reference

29 November 2017

Markus Weber

4

1 reference

29 November 2017

Ulrich Steidl

5

1 reference

29 November 2017

Ulrich-Peter Rohr

6

1 reference

29 November 2017

Thomas Möhler

7

1 reference

29 November 2017

Rainer Haas

8

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

9

1 reference

29 November 2017

issue

7

1 reference

29 November 2017

page(s)

587-596

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700474

29 November 2017

exact match

0 references

cites work

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Potential roles of osteopontin and alphaVbeta3 integrin in the development of coronary artery restenosis after angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Role of integrins in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Stepwise in vitro affinity maturation of Vitaxin, an alphav beta3-specific humanized mAb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Design, synthesis and biological evaluation of nonpeptide integrin antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Antisense strategies for the treatment of hematological malignancies and solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

A theoretical approach to select effective antisense oligodeoxyribonucleotides at high statistical probability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: A comparative study of angiogenesis in Matrigel, collagen, fibrin, and plasma clot

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

The experimental use of antisense oligonucleotides: a guide for the perplexed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Expression of antisense to integrin subunit beta 3 inhibits microvascular endothelial cell capillary tube formation in fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Cloning of mouse integrin alphaV cDNA and role of the alphaV-related matrix receptors in metanephric development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Oligodeoxynucleotide targeted to the alphav gene inhibits alphav integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Integrin expression in human melanoma cells with differing invasive and metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

The role of alpha v-integrins in tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Expression of alphav integrins and vitronectin receptor identity in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of alpha(v) integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Integrin alphavbeta3 promotes anchorage-dependent apoptosis in human intestinal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

An antisense oligonucleotide targeting the alphaV integrin gene inhibits adhesion and induces apoptosis in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

Review: angiogenesis: implications for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

REVIEW: the integrin alpha V beta 3: angiogenesis and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

Basic fibroblast growth factor increases expression of the alpha v beta 3 integrin complex on human microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

Intercellular adhesion molecular 1 on monocytes mediates adhesion as well as trans-endothelial migration and can be downregulated using antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

X-HUSAR, an X-based graphical interface for the analysis of genomic sequences

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

Expression and Modulation of the Vitronectin Receptor on Human Dermal Microvascular Endothelial Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

An in vitro model of angiogenesis: basic features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

In vivo therapy of malignant melanoma by means of antagonists of alphav integrins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700474

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700474

1 reference

29 November 2017

1 reference